Evidence map›Paper›PMID 36889360›Full record

ReviewJournal of hepatology2023

The exposome and liver disease - how environmental factors affect liver health.

Robert Barouki, Michel Samson, Etienne B Blanc, Massimo Colombo, Jessica Zucman-Rossi, Konstantinos N Lazaridis, Gary W Miller, Xavier Coumoul

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
22.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Helicobacter pylori Infection and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Urinary Volatile Organic Compound Metabolites Are Associated With MASLD/MASH in Humans and Induce Steatosis in Liver Organoids.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  9. Review
  10. Microplastics, nanoplastics and liver disease: an emerging health concern?Nature reviews. Gastroenterology & hepatology · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Robert BaroukiUniversité Paris Cité, Inserm T3S, Paris, France. Electronic address: robert.barouki@u-paris.fr.
Michel SamsonUniv Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
Etienne B BlancUniversité Paris Cité, Inserm T3S, Paris, France.
Massimo ColomboSan Raffaele Hospital, Liver Center, Via Olgettina 60, 20132, Milan, Italy.
Jessica Zucman-RossiCentre de Recherche des Cordeliers, Université Paris Cité, Sorbonne Université, Inserm, AP-HP, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, F-75006, Paris, France.
Konstantinos N LazaridisDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55902, USA.
Gary W MillerDepartment of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, 10032, USA.
Xavier CoumoulUniversité Paris Cité, Inserm T3S, Paris, France.
Inserm · FRColumbia University · USDélégation Paris 5 · FRJacksonville College · USVita-Salute San Raffaele University · IT

Funding

Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genomeRC2DK118619 · NIDDK · MAYO CLINIC ROCHESTER · PI LAZARIDIS, KONSTANTINOS N · 2018 to 2022
$7.8M
U2C Experimental CoreU2CES030163 · NIEHS · EMORY UNIVERSITY · PI MORGAN, EDWARD THOMAS · 2018 to 2021
$3.6M
Pathogenesis of Primary Biliary CholangitisR01DK126691 · NIDDK · MAYO CLINIC ROCHESTER · PI LAZARIDIS, KONSTANTINOS N · 2021 to 2024
$2.6M
NIDDK NIH HHS R01 DK126691NIDDK NIH HHS RC2 DK118619NIEHS NIH HHS U2C ES030163
6 · The paper itself

Abstract

Since the initial development of the exposome concept, much effort has been devoted to the characterisation of the exposome through analytical, epidemiological, and toxicological/mechanistic studies. There is now an urgent need to link the exposome to human diseases and to include exposomics in the characterisation of environment-linked pathologies together with genomics and other omics. Liver diseases are particularly well suited for such studies since major functions of the liver include the detection, detoxification, and elimination of xenobiotics, as well as inflammatory responses. It is well known that several liver diseases are associated with i) addictive behaviours such as alcohol consumption, smoking, and to a certain extent dietary imbalance and obesity, ii) viral and parasitic infections, and iii) exposure to toxins and occupational chemicals. Recent studies indicate that environmental exposures are also significantly associated with liver diseases, and these include air pollution (particulate matter and volatile chemicals), contaminants such as polyaromatic hydrocarbons, bisphenol A and per-and poly-fluorinated substances, and physical stressors such as radiation. Furthermore, microbial metabolites and the "gut-liver" axis play a major role in liver diseases. Exposomics is poised to play a major role in the field of liver pathology. Methodological advances such as the exposomics-metabolomics framework, the determination of risk factors' genomic and epigenomic signatures, and cross-species biological pathway analysis should further delineate the impact of the exposome on the liver, opening the way for improved prevention, as well as the identification of new biomarkers of exposure and effects, and additional therapeutic targets.

Indexed as

Air PollutionExposomeLiver DiseasesEnvironmental ExposureHumansbiliary diseaseexposomicshepatocellular carcinomaMAFLDmetabolomicsmicrobiotamutational signaturetoxicological pathwaysviral hepatitisxenobiotic metabolism

Identifiers

PMID36889360
PMCPMC10448911
OpenAlexW4323308613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.